Cell therapy manufacturing is uniquely vulnerable to contamination, variability, and operational burden because the product - ...

Many biological functions are regulated by the switching on and off of mechanisms triggered by the matching of a keyhole ...

A large share of medicines developed today may never reach patients for a surprisingly simple reason: they cannot dissolve well enough in water. For most treatments, the oral route remains the gold ...

CTD402 has received orphan drug designation, offering development incentives for treating rare diseases like T-ALL/LBL, affecting fewer than 200,000 people in the U.S. Early data show CTD402 achieved ...

Abstract: The collection of single-cell level information has become essential in the development of drug molecules, diagnostics, and therapeutics, as cellular responses measured at the population ...

When you take a drug, where in your body does it actually go? For most medications, scientists can make only educated guesses about the answer to this question. Traditional methods can measure the ...

Ginkgo Bioworks has announced the launch of the Virtual Cell Pharmacology Initiative (VCPI) through Ginkgo Datapoints. This open-source platform is designed to build a standardized framework for ...

WASHINGTON, D.C. — The U.S. Food and Drug Administration announced that more than 140,000 bottles of a widely used generic cholesterol drug, atorvastatin calcium, are being voluntarily recalled ...

Add Yahoo as a preferred source to see more of our stories on Google. Over 140,000 bottles of a common cholesterol medication have been recalled because the pills “failed dissolution specifications,” ...

Scientists have made incredible progress in developing cancer therapies that help patients across cancer types. However, they face limitations in determining the results of drug effectiveness, as well ...

OXFORD, England--(BUSINESS WIRE)--At the American Society of Human Genetics (ASHG) 2025 industry session on 16th October, Oxford Nanopore Technologies will share its latest developments in enabling ...